Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Topical ionic contra-viral therapy comprised of digoxin and furosemide as a potential novel treatment approach for common warts.
van der Kolk T, Dillingh MR, Rijneveld R, Klaassen ES, de Koning MNC, Kouwenhoven STP, Genders RE, Bouwes Bavinck JN, Feiss G, Rissmann R, Burggraaf J. van der Kolk T, et al. Among authors: de koning mnc. J Eur Acad Dermatol Venereol. 2017 Dec;31(12):2088-2090. doi: 10.1111/jdv.14527. Epub 2017 Sep 6. J Eur Acad Dermatol Venereol. 2017. PMID: 28833595 Free PMC article.
Developing and validating the Cutaneous WARTS (CWARTS) diagnostic tool: a novel clinical assessment and classification system for cutaneous warts.
Hogendoorn GK, Bruggink SC, Hermans KE, Kouwenhoven STP, Quint KD, Wolterbeek R, Eekhof JAH, de Koning MNC, Rissmann R, Burggraaf J, Bouwes Bavinck JN. Hogendoorn GK, et al. Among authors: de koning mnc. Br J Dermatol. 2018 Feb;178(2):527-534. doi: 10.1111/bjd.15999. Epub 2017 Dec 18. Br J Dermatol. 2018. PMID: 28949011 Clinical Trial.
Results of a randomized, placebo-controlled, first-in-human trial of topical CY-002 in patients with cutaneous warts.
Pagan L, Yfanti C, Rijneveld R, Todd M, Jongste P, Feijen JJ, Klaassen ES, Bouwes Bavinck JN, Struijk L, de Koning MNC, Prestegarden L, Niemeyer-van der Kolk T, van Poelgeest MIE, Rissmann R. Pagan L, et al. Among authors: de koning mnc. J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e773-e775. doi: 10.1111/jdv.18291. Epub 2022 Jun 14. J Eur Acad Dermatol Venereol. 2022. PMID: 35699238 Clinical Trial. No abstract available.
An analysis of clustering of betapapillomavirus antibodies.
Mallitt KA, O'Rourke P, Bouwes Bavinck JN, Abeni D, de Koning MNC, Feltkamp MCW, Green AC, Quint WGV, Michael KM, Pawlita M, Pfister H, Weissenborn S, Waterboer T, Neale RE, The Epi-Hpv-Uv-Ca Group. Mallitt KA, et al. Among authors: de koning mnc. J Gen Virol. 2010 Aug;91(Pt 8):2062-2067. doi: 10.1099/vir.0.017970-0. Epub 2010 Apr 14. J Gen Virol. 2010. PMID: 20392895
66 results